Initially, our in-silico prediction results showed that UBE2O, UBE2T, and USP7 were upregulated in MDS patients when compared with healthy individuals, but only in mononucleated cells collected from bone marrow samples. This evidence concerns the gene UBE2T and myelodysplastic syndrome.